

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.21422749 |
| 2 | cellular response to type I interferon (GO:0071357) | 6.03732155 |
| 3 | type I interferon signaling pathway (GO:0060337) | 6.03732155 |
| 4 | response to type I interferon (GO:0034340) | 6.01205970 |
| 5 | positive regulation of interferon-alpha production (GO:0032727) | 5.62609040 |
| 6 | response to interferon-alpha (GO:0035455) | 5.54800559 |
| 7 | regulation of interferon-alpha production (GO:0032647) | 5.29068438 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.93035636 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.93035636 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.89839478 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.89839478 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.89839478 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.89839478 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.89839478 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.89839478 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.71923348 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.69326707 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.69326707 |
| 19 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.32156940 |
| 20 | response to peptidoglycan (GO:0032494) | 4.28113852 |
| 21 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.19913322 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.18940979 |
| 23 | T cell migration (GO:0072678) | 4.18204143 |
| 24 | negative regulation of viral genome replication (GO:0045071) | 4.15325977 |
| 25 | cellular response to interferon-alpha (GO:0035457) | 4.15108217 |
| 26 | cellular response to exogenous dsRNA (GO:0071360) | 4.14656413 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 4.10834757 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.09396610 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 4.07449171 |
| 30 | cellular response to interferon-beta (GO:0035458) | 4.05456442 |
| 31 | positive regulation of interferon-beta production (GO:0032728) | 4.03733746 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 3.93843161 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.91870803 |
| 34 | response to host immune response (GO:0052572) | 3.91870803 |
| 35 | response to interferon-beta (GO:0035456) | 3.90172992 |
| 36 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.86854093 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.76315780 |
| 38 | cellular response to virus (GO:0098586) | 3.71058576 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.70623069 |
| 40 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.58985045 |
| 41 | detection of bacterium (GO:0016045) | 3.51714862 |
| 42 | detection of external biotic stimulus (GO:0098581) | 3.48925407 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.47242019 |
| 44 | positive regulation of type 2 immune response (GO:0002830) | 3.45382973 |
| 45 | response to host (GO:0075136) | 3.45312551 |
| 46 | response to host defenses (GO:0052200) | 3.45312551 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.45312551 |
| 48 | lymphocyte chemotaxis (GO:0048247) | 3.44615573 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.43814185 |
| 50 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.42932677 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.42664036 |
| 52 | T-helper 1 type immune response (GO:0042088) | 3.42077829 |
| 53 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.36273309 |
| 54 | * regulation of RIG-I signaling pathway (GO:0039535) | 3.36120406 |
| 55 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.35642065 |
| 56 | * defense response to virus (GO:0051607) | 3.35433697 |
| 57 | cellular response to interferon-gamma (GO:0071346) | 3.34150554 |
| 58 | defense response to protozoan (GO:0042832) | 3.30580673 |
| 59 | cellular extravasation (GO:0045123) | 3.28376714 |
| 60 | respiratory burst (GO:0045730) | 3.27685935 |
| 61 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.26189457 |
| 62 | response to muramyl dipeptide (GO:0032495) | 3.24889340 |
| 63 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.24362730 |
| 64 | regulation of viral genome replication (GO:0045069) | 3.21260058 |
| 65 | regulation of type 2 immune response (GO:0002828) | 3.20876917 |
| 66 | positive regulation of defense response to virus by host (GO:0002230) | 3.16455082 |
| 67 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16322640 |
| 68 | microglial cell activation (GO:0001774) | 3.15851337 |
| 69 | response to interleukin-15 (GO:0070672) | 3.15047314 |
| 70 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.12611579 |
| 71 | B cell mediated immunity (GO:0019724) | 3.12481298 |
| 72 | positive regulation of interleukin-12 production (GO:0032735) | 3.11612661 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 3.09067441 |
| 74 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.08713910 |
| 75 | regulation of necroptotic process (GO:0060544) | 3.07788454 |
| 76 | regulation of defense response to virus by host (GO:0050691) | 3.06859809 |
| 77 | regulation of T cell tolerance induction (GO:0002664) | 3.06249822 |
| 78 | neutrophil activation (GO:0042119) | 3.05702029 |
| 79 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.05579068 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.04923486 |
| 81 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04511854 |
| 82 | regulation of regulatory T cell differentiation (GO:0045589) | 3.03318831 |
| 83 | negative regulation of viral process (GO:0048525) | 3.02964887 |
| 84 | natural killer cell mediated immunity (GO:0002228) | 3.01483031 |
| 85 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.01483031 |
| 86 | regulation of interferon-beta production (GO:0032648) | 3.01325773 |
| 87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00441436 |
| 88 | detection of biotic stimulus (GO:0009595) | 3.00399122 |
| 89 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.99985294 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.99663801 |
| 91 | detection of other organism (GO:0098543) | 2.99532664 |
| 92 | granulocyte activation (GO:0036230) | 2.98611976 |
| 93 | response to interferon-gamma (GO:0034341) | 2.98567697 |
| 94 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.98214062 |
| 95 | leukocyte aggregation (GO:0070486) | 2.96701809 |
| 96 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.96316940 |
| 97 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.96192604 |
| 98 | response to protozoan (GO:0001562) | 2.95758935 |
| 99 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95678306 |
| 100 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.95481694 |
| 101 | cellular response to interleukin-15 (GO:0071350) | 2.95342162 |
| 102 | negative thymic T cell selection (GO:0045060) | 2.94799210 |
| 103 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.94222043 |
| 104 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93759937 |
| 105 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93759937 |
| 106 | regulation of gamma-delta T cell activation (GO:0046643) | 2.93435740 |
| 107 | mature B cell differentiation (GO:0002335) | 2.92640361 |
| 108 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92628012 |
| 109 | negative T cell selection (GO:0043383) | 2.92218220 |
| 110 | regulation of natural killer cell differentiation (GO:0032823) | 2.91843607 |
| 111 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88807014 |
| 112 | positive regulation of T cell cytokine production (GO:0002726) | 2.88218060 |
| 113 | regulation of tolerance induction (GO:0002643) | 2.87823186 |
| 114 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87463602 |
| 115 | regulation of chemokine biosynthetic process (GO:0045073) | 2.86893527 |
| 116 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.85715377 |
| 117 | eosinophil chemotaxis (GO:0048245) | 2.85327347 |
| 118 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.84266639 |
| 119 | positive regulation of interleukin-17 production (GO:0032740) | 2.84053806 |
| 120 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.82523238 |
| 121 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.81561185 |
| 122 | interferon-gamma secretion (GO:0072643) | 2.81457098 |
| 123 | detection of molecule of bacterial origin (GO:0032490) | 2.81399089 |
| 124 | regulation of activation of Janus kinase activity (GO:0010533) | 2.80188545 |
| 125 | regulation of response to interferon-gamma (GO:0060330) | 2.79336095 |
| 126 | regulation of antigen processing and presentation (GO:0002577) | 2.78670668 |
| 127 | monocyte chemotaxis (GO:0002548) | 2.78233517 |
| 128 | macrophage activation (GO:0042116) | 2.76307907 |
| 129 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.75858590 |
| 130 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.74683354 |
| 131 | natural killer cell activation (GO:0030101) | 2.74676798 |
| 132 | negative regulation of type I interferon production (GO:0032480) | 2.74565481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.14469107 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.54608470 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.18584890 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.44904016 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.75543741 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.89697641 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.62649727 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.58041445 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.47907745 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.30082604 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.24154881 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06383636 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.95156417 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.94108616 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.68983589 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.68501443 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.65861488 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.48042549 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46290494 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07768691 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.88014232 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87699134 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 1.87507723 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86812095 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.86133728 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85406403 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73360203 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73205137 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.63094114 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61839115 |
| 31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61178765 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61002773 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58938842 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57872862 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55335262 |
| 36 | * MAF_26560356_Chip-Seq_TH1_Human | 1.53645760 |
| 37 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42834034 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42741371 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41507030 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35609348 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34416462 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33136964 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30204198 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29325914 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28605441 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27493845 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26581716 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25382262 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23479440 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22589066 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22097228 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20401497 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20113227 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19971289 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15826037 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13770639 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09709357 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04997036 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04628221 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03588892 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96395336 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96081588 |
| 63 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94949245 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91312066 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90750316 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88772167 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88399670 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87195677 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86852564 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86623350 |
| 71 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85322294 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83060630 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81699368 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81679203 |
| 75 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80483198 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79935522 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.79499834 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78813701 |
| 79 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.78309453 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76583818 |
| 81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.75910087 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.75594883 |
| 83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.75187105 |
| 84 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.74398553 |
| 85 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74248385 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74152488 |
| 87 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74054852 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 0.73982372 |
| 89 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73948058 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.73021600 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.72597635 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.71952129 |
| 93 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71549468 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.71159574 |
| 95 | MYC_22102868_ChIP-Seq_BL_Human | 0.70428237 |
| 96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.69955253 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68530080 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68512475 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.68427116 |
| 100 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68264811 |
| 101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67370576 |
| 102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.67105747 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.66311922 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.65947742 |
| 105 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64359368 |
| 106 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63868669 |
| 107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.63513016 |
| 108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63357042 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.63022009 |
| 110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.60929826 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.60929826 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.60041813 |
| 113 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.60018476 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59733076 |
| 115 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59347464 |
| 116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.58764811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.67540940 |
| 2 | MP0009785_altered_susceptibility_to | 4.43567347 |
| 3 | MP0003724_increased_susceptibility_to | 3.71980917 |
| 4 | MP0005671_abnormal_response_to | 3.31361239 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.22388368 |
| 6 | MP0003436_decreased_susceptibility_to | 3.19708152 |
| 7 | MP0005025_abnormal_response_to | 3.15805813 |
| 8 | MP0005387_immune_system_phenotype | 3.09069564 |
| 9 | MP0001790_abnormal_immune_system | 3.09069564 |
| 10 | MP0000685_abnormal_immune_system | 3.01627492 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.96156151 |
| 12 | MP0006082_CNS_inflammation | 2.90837370 |
| 13 | MP0002419_abnormal_innate_immunity | 2.86962243 |
| 14 | MP0001800_abnormal_humoral_immune | 2.68942964 |
| 15 | MP0002723_abnormal_immune_serum | 2.64925724 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.64694767 |
| 17 | MP0001819_abnormal_immune_cell | 2.36238657 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.31917210 |
| 19 | MP0004510_myositis | 2.15327903 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.10291713 |
| 21 | MP0010155_abnormal_intestine_physiology | 2.07592290 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.06078662 |
| 23 | MP0004947_skin_inflammation | 2.02684726 |
| 24 | MP0001853_heart_inflammation | 1.97207420 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.96623842 |
| 26 | MP0009764_decreased_sensitivity_to | 1.95680829 |
| 27 | MP0002006_tumorigenesis | 1.94161234 |
| 28 | MP0003303_peritoneal_inflammation | 1.92962194 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.89636418 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.89475970 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.87637631 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.84284511 |
| 33 | MP0000716_abnormal_immune_system | 1.79003760 |
| 34 | MP0002405_respiratory_system_inflammati | 1.78526001 |
| 35 | MP0008469_abnormal_protein_level | 1.78095836 |
| 36 | MP0002398_abnormal_bone_marrow | 1.75696930 |
| 37 | MP0003448_altered_tumor_morphology | 1.57967887 |
| 38 | MP0009840_abnormal_foam_cell | 1.57840019 |
| 39 | MP0002254_reproductive_system_inflammat | 1.51389413 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.50665766 |
| 41 | MP0009278_abnormal_bone_marrow | 1.50210245 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.48292624 |
| 43 | MP0005451_abnormal_body_composition | 1.47459012 |
| 44 | MP0000343_altered_response_to | 1.44381866 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.43786629 |
| 46 | MP0002429_abnormal_blood_cell | 1.42693862 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.41462399 |
| 48 | MP0000858_altered_metastatic_potential | 1.37147898 |
| 49 | MP0002722_abnormal_immune_system | 1.36247146 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.36105553 |
| 51 | MP0005310_abnormal_salivary_gland | 1.34429237 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.32988740 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.32988740 |
| 54 | MP0005360_urolithiasis | 1.26423584 |
| 55 | MP0004883_abnormal_blood_vessel | 1.25981722 |
| 56 | MP0004381_abnormal_hair_follicle | 1.24876019 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.23581233 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.23501576 |
| 59 | MP0003075_altered_response_to | 1.20584725 |
| 60 | MP0009763_increased_sensitivity_to | 1.20232927 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.19361564 |
| 62 | MP0003045_fibrosis | 1.18539429 |
| 63 | MP0003866_abnormal_defecation | 1.13423987 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.10189349 |
| 65 | MP0008004_abnormal_stomach_pH | 1.10111148 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.07282586 |
| 67 | MP0002332_abnormal_exercise_endurance | 1.00741682 |
| 68 | MP0005166_decreased_susceptibility_to | 0.99432116 |
| 69 | MP0002396_abnormal_hematopoietic_system | 0.96867612 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.96333561 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 0.95019378 |
| 72 | MP0003828_pulmonary_edema | 0.93442868 |
| 73 | MP0005174_abnormal_tail_pigmentation | 0.92957505 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 0.92547335 |
| 75 | MP0000604_amyloidosis | 0.91202001 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89403242 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 0.88500953 |
| 78 | MP0001663_abnormal_digestive_system | 0.87869322 |
| 79 | MP0000371_diluted_coat_color | 0.86100642 |
| 80 | MP0010352_gastrointestinal_tract_polyps | 0.86053336 |
| 81 | MP0001873_stomach_inflammation | 0.85835378 |
| 82 | MP0000703_abnormal_thymus_morphology | 0.85601320 |
| 83 | MP0003252_abnormal_bile_duct | 0.84629224 |
| 84 | MP0005390_skeleton_phenotype | 0.82972442 |
| 85 | MP0006054_spinal_hemorrhage | 0.80351490 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.80034504 |
| 87 | MP0002132_abnormal_respiratory_system | 0.79961744 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.79415892 |
| 89 | MP0000249_abnormal_blood_vessel | 0.79209279 |
| 90 | MP0005164_abnormal_response_to | 0.78487724 |
| 91 | MP0002139_abnormal_hepatobiliary_system | 0.77029054 |
| 92 | MP0001851_eye_inflammation | 0.76316867 |
| 93 | MP0008874_decreased_physiological_sensi | 0.73391465 |
| 94 | MP0002933_joint_inflammation | 0.72615699 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.71722651 |
| 96 | MP0001958_emphysema | 0.71159463 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.71133939 |
| 98 | MP0003091_abnormal_cell_migration | 0.70523481 |
| 99 | MP0003186_abnormal_redox_activity | 0.70335170 |
| 100 | MP0002796_impaired_skin_barrier | 0.68672560 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.66694000 |
| 102 | MP0000015_abnormal_ear_pigmentation | 0.66580720 |
| 103 | MP0000609_abnormal_liver_physiology | 0.65993608 |
| 104 | MP0001666_abnormal_nutrient_absorption | 0.64450563 |
| 105 | MP0002009_preneoplasia | 0.62922408 |
| 106 | MP0004484_altered_response_of | 0.62521997 |
| 107 | MP0003690_abnormal_glial_cell | 0.61695254 |
| 108 | MP0005023_abnormal_wound_healing | 0.61213883 |
| 109 | MP0010307_abnormal_tumor_latency | 0.61002831 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 0.59661699 |
| 111 | MP0000490_abnormal_crypts_of | 0.58622447 |
| 112 | MP0003795_abnormal_bone_structure | 0.57208986 |
| 113 | MP0001881_abnormal_mammary_gland | 0.55860421 |
| 114 | MP0001191_abnormal_skin_condition | 0.50182348 |
| 115 | MP0008260_abnormal_autophagy | 0.49300265 |
| 116 | MP0002019_abnormal_tumor_incidence | 0.49140047 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.49080189 |
| 118 | MP0001764_abnormal_homeostasis | 0.47802647 |
| 119 | MP0009643_abnormal_urine_homeostasis | 0.47249947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.92030494 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.59138371 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.15483323 |
| 4 | Autoimmune thrombocytopenia (HP:0001973) | 5.03759988 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.64716772 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.30075743 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.29628810 |
| 8 | Increased IgM level (HP:0003496) | 4.13760448 |
| 9 | Recurrent viral infections (HP:0004429) | 4.08333493 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.99878831 |
| 11 | Myositis (HP:0100614) | 3.97955286 |
| 12 | Abnormality of macrophages (HP:0004311) | 3.89211634 |
| 13 | Chronic otitis media (HP:0000389) | 3.85422821 |
| 14 | Recurrent skin infections (HP:0001581) | 3.81890495 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.80900268 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.80900268 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.72997333 |
| 18 | Vasculitis (HP:0002633) | 3.69042105 |
| 19 | Orchitis (HP:0100796) | 3.64893743 |
| 20 | Optic neuritis (HP:0100653) | 3.57531705 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.57531705 |
| 22 | Autoimmune hemolytic anemia (HP:0001890) | 3.53651655 |
| 23 | Gingivitis (HP:0000230) | 3.51834393 |
| 24 | Stomatitis (HP:0010280) | 3.43953450 |
| 25 | Basal ganglia calcification (HP:0002135) | 3.38325873 |
| 26 | Prostate neoplasm (HP:0100787) | 3.36132989 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 3.25295863 |
| 28 | Hypergammaglobulinemia (HP:0010702) | 3.18444356 |
| 29 | Periodontitis (HP:0000704) | 3.15365107 |
| 30 | Chronic diarrhea (HP:0002028) | 3.05439886 |
| 31 | Pustule (HP:0200039) | 3.03861980 |
| 32 | Gingival bleeding (HP:0000225) | 2.94139439 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92446539 |
| 34 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.92278129 |
| 35 | Leukocytosis (HP:0001974) | 2.92242466 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.91212713 |
| 37 | Recurrent bronchitis (HP:0002837) | 2.88446751 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87808015 |
| 39 | Obstructive lung disease (HP:0006536) | 2.87808015 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.86305989 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.86248291 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.86248291 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.86248291 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.84655803 |
| 45 | Axonal loss (HP:0003447) | 2.84502388 |
| 46 | Severe combined immunodeficiency (HP:0004430) | 2.81107591 |
| 47 | Eosinophilia (HP:0001880) | 2.80048763 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.76482192 |
| 49 | Nasal polyposis (HP:0100582) | 2.74152267 |
| 50 | Hemoptysis (HP:0002105) | 2.73733584 |
| 51 | Colitis (HP:0002583) | 2.73670068 |
| 52 | Abnormality of T cells (HP:0002843) | 2.71639610 |
| 53 | Thyroiditis (HP:0100646) | 2.69462060 |
| 54 | Combined immunodeficiency (HP:0005387) | 2.67246497 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.65130598 |
| 56 | Abnormality of eosinophils (HP:0001879) | 2.64744506 |
| 57 | Arterial thrombosis (HP:0004420) | 2.64543339 |
| 58 | Premature loss of primary teeth (HP:0006323) | 2.61620318 |
| 59 | Meningitis (HP:0001287) | 2.61031853 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 2.59699267 |
| 61 | T lymphocytopenia (HP:0005403) | 2.56265312 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.55179034 |
| 63 | Peritonitis (HP:0002586) | 2.54006011 |
| 64 | Joint swelling (HP:0001386) | 2.49379393 |
| 65 | Granulocytopenia (HP:0001913) | 2.47392660 |
| 66 | Increased IgE level (HP:0003212) | 2.42572430 |
| 67 | Panhypogammaglobulinemia (HP:0003139) | 2.41800959 |
| 68 | Loss of speech (HP:0002371) | 2.41645651 |
| 69 | Cheilitis (HP:0100825) | 2.38500110 |
| 70 | Malnutrition (HP:0004395) | 2.38335970 |
| 71 | IgG deficiency (HP:0004315) | 2.37966547 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37848425 |
| 73 | Cellulitis (HP:0100658) | 2.36968389 |
| 74 | Tetraparesis (HP:0002273) | 2.36749241 |
| 75 | Gangrene (HP:0100758) | 2.36105980 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.35922227 |
| 77 | Petechiae (HP:0000967) | 2.33918952 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.33510711 |
| 79 | Thick nail (HP:0001805) | 2.33296521 |
| 80 | Agammaglobulinemia (HP:0004432) | 2.32676197 |
| 81 | IgA deficiency (HP:0002720) | 2.32198728 |
| 82 | Epistaxis (HP:0000421) | 2.31240000 |
| 83 | Porencephaly (HP:0002132) | 2.30246198 |
| 84 | Abnormality of the prostate (HP:0008775) | 2.29386550 |
| 85 | Slow saccadic eye movements (HP:0000514) | 2.29250409 |
| 86 | Keratoconjunctivitis sicca (HP:0001097) | 2.28996808 |
| 87 | Joint hemorrhage (HP:0005261) | 2.27891203 |
| 88 | Osteomyelitis (HP:0002754) | 2.27246849 |
| 89 | Pulmonary embolism (HP:0002204) | 2.27235948 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 2.26932226 |
| 91 | Lymphopenia (HP:0001888) | 2.21214574 |
| 92 | Myocardial infarction (HP:0001658) | 2.21154758 |
| 93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.21008855 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 2.19693652 |
| 95 | Prolonged bleeding time (HP:0003010) | 2.18340744 |
| 96 | Thrombocytosis (HP:0001894) | 2.18086007 |
| 97 | Urticaria (HP:0001025) | 2.17316773 |
| 98 | Anorexia (HP:0002039) | 2.17144603 |
| 99 | Encephalitis (HP:0002383) | 2.17080359 |
| 100 | Recurrent pneumonia (HP:0006532) | 2.12486019 |
| 101 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11035306 |
| 102 | Osteolytic defects of the hand bones (HP:0009699) | 2.11035306 |
| 103 | Chronic sinusitis (HP:0011109) | 2.11018992 |
| 104 | Keratoconjunctivitis (HP:0001096) | 2.10508992 |
| 105 | IgM deficiency (HP:0002850) | 2.08770430 |
| 106 | Hematochezia (HP:0002573) | 2.08505214 |
| 107 | Recurrent lower respiratory tract infections (HP:0002783) | 2.07070082 |
| 108 | Abnormality of the pleura (HP:0002103) | 2.05866357 |
| 109 | Keratitis (HP:0000491) | 2.03672376 |
| 110 | Dysostosis multiplex (HP:0000943) | 2.01363099 |
| 111 | Glomerulopathy (HP:0100820) | 1.99705250 |
| 112 | Nephritis (HP:0000123) | 1.98868464 |
| 113 | Episodic fever (HP:0001954) | 1.98812776 |
| 114 | Chest pain (HP:0100749) | 1.98680535 |
| 115 | Skin ulcer (HP:0200042) | 1.96937988 |
| 116 | Progressive visual loss (HP:0000529) | 1.93273630 |
| 117 | Abnormality of B cell number (HP:0010975) | 1.91346381 |
| 118 | Abnormality of the endocardium (HP:0004306) | 1.91099920 |
| 119 | Amyloidosis (HP:0011034) | 1.86204748 |
| 120 | Increased CSF protein (HP:0002922) | 1.85729178 |
| 121 | Bronchitis (HP:0012387) | 1.84580804 |
| 122 | Viral hepatitis (HP:0006562) | 1.84015562 |
| 123 | Abnormality of the pericardium (HP:0001697) | 1.80813517 |
| 124 | Subacute progressive viral hepatitis (HP:0006572) | 1.78803947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IKBKE | 4.41999178 |
| 2 | MAP3K14 | 4.19359396 |
| 3 | TYK2 | 4.18682834 |
| 4 | TBK1 | 3.55523520 |
| 5 | JAK3 | 3.54576811 |
| 6 | TXK | 3.19247077 |
| 7 | FGFR4 | 2.93980367 |
| 8 | JAK1 | 2.86906050 |
| 9 | IRAK4 | 2.83925931 |
| 10 | KIT | 2.65426412 |
| 11 | BLK | 2.39578959 |
| 12 | MAP4K1 | 2.36340142 |
| 13 | IKBKB | 2.34574510 |
| 14 | PIK3CG | 2.30697808 |
| 15 | RIPK4 | 2.23586343 |
| 16 | MAP3K3 | 2.05730987 |
| 17 | MST4 | 1.94332856 |
| 18 | PRPF4B | 1.93841166 |
| 19 | IRAK3 | 1.92724139 |
| 20 | MAP3K13 | 1.89884956 |
| 21 | ZAP70 | 1.86954259 |
| 22 | TAOK2 | 1.82645375 |
| 23 | TAOK1 | 1.82092453 |
| 24 | FGFR3 | 1.79085923 |
| 25 | PBK | 1.75196226 |
| 26 | TAOK3 | 1.69923226 |
| 27 | CHUK | 1.52803702 |
| 28 | MAP3K11 | 1.49802714 |
| 29 | CSK | 1.48580106 |
| 30 | BTK | 1.45317007 |
| 31 | TEC | 1.45117795 |
| 32 | BMPR2 | 1.35598107 |
| 33 | EPHA3 | 1.34731280 |
| 34 | TGFBR2 | 1.30179989 |
| 35 | LCK | 1.30175474 |
| 36 | EPHB1 | 1.28066926 |
| 37 | RPS6KA4 | 1.26587343 |
| 38 | ERN1 | 1.23418141 |
| 39 | EIF2AK2 | 1.21833997 |
| 40 | SYK | 1.20364641 |
| 41 | HCK | 1.19772533 |
| 42 | NLK | 1.18892953 |
| 43 | JAK2 | 1.02801220 |
| 44 | LYN | 1.02625208 |
| 45 | PIM2 | 0.99121676 |
| 46 | CSF1R | 0.97858200 |
| 47 | NEK9 | 0.94492848 |
| 48 | IRAK1 | 0.94097022 |
| 49 | STK10 | 0.93185461 |
| 50 | ITK | 0.91673038 |
| 51 | TRPM7 | 0.88715315 |
| 52 | NUAK1 | 0.88181980 |
| 53 | TNK2 | 0.84316256 |
| 54 | PIM1 | 0.83400348 |
| 55 | MAP3K12 | 0.83113626 |
| 56 | MAPKAPK3 | 0.81204279 |
| 57 | MAP2K3 | 0.80625457 |
| 58 | MATK | 0.80133969 |
| 59 | BMPR1B | 0.76182417 |
| 60 | STK4 | 0.75914091 |
| 61 | CDC42BPA | 0.75186238 |
| 62 | CLK1 | 0.74828791 |
| 63 | FGR | 0.72291050 |
| 64 | MAP3K2 | 0.68873618 |
| 65 | KDR | 0.66876001 |
| 66 | MAPK11 | 0.64890616 |
| 67 | ADRBK2 | 0.63465289 |
| 68 | ACVR1B | 0.59923548 |
| 69 | MAP3K5 | 0.59739056 |
| 70 | FLT3 | 0.56808779 |
| 71 | FES | 0.56284868 |
| 72 | TGFBR1 | 0.55864316 |
| 73 | TIE1 | 0.55787731 |
| 74 | CAMKK2 | 0.54845177 |
| 75 | MAP3K6 | 0.51431042 |
| 76 | ERBB3 | 0.50570172 |
| 77 | PDGFRB | 0.50311159 |
| 78 | MAPK7 | 0.49611066 |
| 79 | RIPK1 | 0.49156825 |
| 80 | EGFR | 0.47859309 |
| 81 | PRKCQ | 0.47290416 |
| 82 | MST1R | 0.47148261 |
| 83 | GRK7 | 0.46683734 |
| 84 | PRKCD | 0.46398792 |
| 85 | SIK3 | 0.45983784 |
| 86 | IGF1R | 0.45508738 |
| 87 | MARK3 | 0.45040111 |
| 88 | FER | 0.44725510 |
| 89 | PTK2B | 0.41465578 |
| 90 | YES1 | 0.40726357 |
| 91 | ABL1 | 0.40279690 |
| 92 | STK3 | 0.40119118 |
| 93 | RPS6KA5 | 0.39821948 |
| 94 | STK24 | 0.38837902 |
| 95 | PDPK1 | 0.38330137 |
| 96 | DDR2 | 0.38290200 |
| 97 | PRKD2 | 0.37536732 |
| 98 | PTK6 | 0.37375192 |
| 99 | TNIK | 0.36943538 |
| 100 | MELK | 0.36873493 |
| 101 | CDK4 | 0.34925776 |
| 102 | BMX | 0.34646083 |
| 103 | FRK | 0.33400734 |
| 104 | SGK3 | 0.33310878 |
| 105 | MAP2K6 | 0.31676716 |
| 106 | PIK3CA | 0.30957113 |
| 107 | PRKG2 | 0.30220403 |
| 108 | LRRK2 | 0.30112814 |
| 109 | GRK6 | 0.29635783 |
| 110 | SGK2 | 0.27279085 |
| 111 | CDK6 | 0.26604856 |
| 112 | RET | 0.25488027 |
| 113 | FYN | 0.25401335 |
| 114 | MAPKAPK2 | 0.24042574 |
| 115 | HIPK2 | 0.23485265 |
| 116 | IRAK2 | 0.23000427 |
| 117 | INSR | 0.21039522 |
| 118 | GRK1 | 0.19946637 |
| 119 | MAP3K10 | 0.17627136 |
| 120 | MAPK3 | 0.14918366 |
| 121 | NME2 | 0.14422270 |
| 122 | PDK1 | 0.14044790 |
| 123 | MAP3K1 | 0.13806664 |
| 124 | MOS | 0.13721654 |
| 125 | MYLK | 0.13237831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.12217166 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.11986448 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.07895034 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.01400214 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89714052 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.86243580 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.78230073 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.69308985 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.56095255 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.55273862 |
| 11 | Influenza A_Homo sapiens_hsa05164 | 2.39256365 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.30467576 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.26752813 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.20611264 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 2.16299032 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.10620813 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09006963 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.95220697 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.90188176 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.88261556 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.85155213 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72112733 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.66030382 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62530021 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59869917 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59673465 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.59007964 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56392837 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.55670137 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 1.54125624 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.51477025 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.50677550 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49640640 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.48036098 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42895782 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41178803 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38263834 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.30555941 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30544482 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.25944282 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.19915237 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12441326 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.05202702 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98817606 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98615819 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.94601273 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.89403918 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86878746 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85312662 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85221620 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80848391 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80466542 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.77335110 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73425341 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71429153 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69905507 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.68696717 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67697343 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65692445 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65471901 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61463606 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60965972 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.60037851 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59219253 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58936321 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52846788 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.52488677 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50868428 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50319225 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49505874 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.49494208 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48715546 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47990432 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41262850 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39505830 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38172489 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37914835 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36711343 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36327309 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36218326 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.36101110 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.35547941 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35449074 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33401202 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32731487 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32106593 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31897961 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.31288863 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30496596 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30419774 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29252311 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28325907 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.27684482 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27052452 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.26833004 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26336065 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25879140 |
| 98 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25222134 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24801786 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24651932 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24592470 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.24406729 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24099410 |
| 104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.23745511 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22133043 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21987535 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21522864 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.20526751 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20462880 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20040866 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19399559 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19343223 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16197697 |
| 114 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.15306773 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14365132 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.13259747 |
| 117 | Peroxisome_Homo sapiens_hsa04146 | 0.10456984 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10313379 |

